Table 6. Perioperative parameters of patients who underwent biportal video-assisted thoracoscopic sleeve lobectomy.

Parameters	Values
Median age, years, [IQR]	57 [52–62]
Sex, n (%)
Male	5 (71.4)
Female	2 (28.6)
Neoadjuvant therapy, n (%)	0
Median maximal lesion size, cm, [IQR]	3 [1.5–4]
Lesion location, n (%)
Left upper lobe	3 (42.9)
Right upper lobe	4 (57.1)
Histological type, n (%)
Squamous cell carcinoma	4 (57.1)
Adenocarcinoma	1 (14.3)
Atypical carcinoid	1 (14.3)
Mucoepidermoid carcinoma	1 (14.3)
Median operative time, min, [IQR]	255 [179–360]
Median blood loss, mL, [IQR]	200 [100–600]
Median mediastinal lymph nodes dissected, n [IQR]
Stations	3 [3–4]
Numbers	8 [3–12]
TNM stage, n (%)
IB	3(42.9)
IIB	3 (42.9)
IIIA	1 (14.3)
Median POD 1 drainage volume, ml, [IQR]	370 [250–400]
Median chest tube duration, days, [IQR]	4 [3–6]
Median postoperative length of stay, days, [IQR]	5 [5–8]
Postoperative early complications (grade ≥2), n (%)
Prolonged air leakage >7 days	1 (14.3)
Bacterial pneumonia	1 (14.3)

POD 1, postoperative day 1; IQR, interquartile range.